ASTION PHARMA A/S: Financial statements 2013
CVR: 34224781
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -804,182 and a net result of DKK -1,508,697 compared with DKK -1,941,913 the year before. Equity in the 2013 report amounted to DKK 24,755,936. The solvency ratio was 58.5%.
- Gross Profit
- DKK -804,182
- Profit/Loss
- DKK -1,508,697
- Equity
- DKK 24,755,936
- Total Assets
- DKK 42,303,021
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -804 t. | -1.5 mio. | 24.8 mio. | - |
| 2012 | - | -1.1 mio. | -1.9 mio. | 26.3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ASTION PHARMA A/S has published its annual report for 2012. Gross profit came to DKK -1,109,724, and the net result was DKK -1,941,913.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.